| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 35,800 | 36,020 | 15:32 | |
| 35,800 | 36,020 | 15:32 |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 35,985 | 840 | |||
| 35,965 | 1.125 | |||
| 35,960 | 130 | |||
| 35,935 | 150 | |||
| 35,910 | 1.125 | |||
| 35,870 | 325 | |||
| 35,865 | 32 | |||
| 35,855 | 138 | |||
| 35,850 | 207 | |||
| 35,830 | 557 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/0qf.htm [/URL] | ||||
| 75 | 35,700 | |||
| 303 | 35,620 | |||
| 320 | 35,615 | |||
| 312 | 35,585 | |||
| 1.465 | 35,580 | |||
| 303 | 35,575 | |||
| 150 | 35,560 | |||
| 400 | 35,550 | |||
| 1.125 | 35,525 | |||
| 1 | 35,515 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 4.454 | 1,039 | 4.629 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 15:03:05 | 35,890 | 138 |
| 15:01:42 | 35,835 | 30 |
| 14:46:34 | 35,935 | 27 |
| 14:46:34 | 35,935 | 143 |
| 13:53:00 | 35,910 | 2 |
| 13:36:28 | 35,975 | 5 |
| 13:31:40 | 36,055 | 30 |
| 12:57:58 | 35,965 | 1 |
| 12:56:16 | 35,965 | 46 |
| 12:52:28 | 36,005 | 79 |
| 12:49:34 | 35,990 | 135 |
| 12:48:05 | 35,940 | 75 |
| 12:42:36 | 35,990 | 200 |
| 12:09:58 | 36,010 | 74 |
| 12:07:07 | 35,925 | 142 |
| 12:03:04 | 35,950 | 187 |
| 11:49:42 | 35,990 | 1 |
| 11:43:49 | 36,060 | 76 |
| 11:43:49 | 36,060 | 74 |
| 11:31:53 | 36,120 | 1 |
| Tagesumsatz Xetra | -1,425 -3,82 % | 7.176 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Arbutus jumps on ruling in patent dispute with Moderna | 44 | Seeking Alpha | ||
| Mo | MODERNA INC im Fokus: Schwäche als Prüfstein | 24 | Maximilian Berger | ||
| Fr | Moderna announces departure of medical chief | 21 | Seeking Alpha | ||
| Fr | Moderna's latest CMO steps down after barely a year | 13 | FierceBiotech | ||
| MODERNA Aktie jetzt für 0€ handeln | |||||
| Fr | Führungswechsel bei Moderna: David Berman wird neuer Entwicklungschef | 30 | Investing.com Deutsch |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| Di | Amgen Reports Fourth Quarter And Full Year 2025 Financial Results | PR Newswire | THOUSAND OAKS, Calif., Feb. 3, 2026 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced financial results for the fourth quarter and full year of 2025 versus the... ► Artikel lesen | |
| 14:21 | Aktien New York Ausblick: Keine Tech-Erholung - Eli Lilly steigen kräftig | dpa-AFX | NEW YORK (dpa-AFX) - Mit Blick auf den Technologiesektor dürften sich die Investoren an den US-Börsen am Mittwoch zurückhalten. Der Nasdaq 100 Index, der am Vortag deutlich gefallen war, dürfte sich... ► Artikel lesen | |
| 10:42 | Cereno Scientific broadens development focus for CS014 to pulmonary hypertension associated with interstitial lung disease | PR Newswire | GOTHENBURG, Sweden, Feb. 4, 2026 /PRNewswire/ -- Cereno Scientific (NASDAQ First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare... ► Artikel lesen | |
| 13:02 | Microbix Biosystems Inc.: Microbix Presents Molecular Pathology Platform Results | ACCESS Newswire | Novel Quality Controls to Enable QC & Inter-Laboratory Standardization MISSISSAUGA, ON / ACCESS Newswire / February 4, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix), a life sciences... ► Artikel lesen | |
| 14:02 | Ainos, Inc.: Water Tower Research Fireside Chat with Ainos: AI Nose Powering SmellTech Expansion and Scalable Value Creation | ACCESS Newswire | AI Nose advances through a dual-engine architecture, enabling scalable deploymentsIndustrial and semiconductor deployments broaden Ainos' commercial footprintRobotics momentum accelerates data flywheel... ► Artikel lesen |